Scholars@Duke

Amgen AMG 757 (SCLC)

Clinical Trial Grant
Duke Scholars
Jeffrey Melson Clarke
Principal Investigator Jeffrey Melson Clarke Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Amgen, Inc.

Start Date

October 12, 2022

End Date

September 30, 2027
 

Administered By

Duke Cancer Institute

Awarded By

Amgen, Inc.

Start Date

October 12, 2022

End Date

September 30, 2027